Arkolith/Insider Trading/AVTE/Form 4

Verwijs Marinus

CHIEF TECHNICAL OFFICERAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed Jun 14, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$265K
Net Open-Market Flow
-$265K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 14, 2024Sell(S)11K$25.00$265K0
Jun 14, 2024Option exercise(M)11K$14.59$155K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 14, 2024Option exercise(M)11K—$069K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-016994) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML